Document Detail


Romidepsin induces cell cycle arrest, apoptosis, histone hyperacetylation and reduces matrix metalloproteinases 2 and 9 expression in bortezomib sensitized non-small cell lung cancer cells.
MedLine Citation:
PMID:  24485799     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Histone deacetylase (HDAC) inhibitors have been proven to be effective therapeutic agents to kill cancer cells through inhibiting HDAC activity or altering the structure of chromatin. We recently reported that chemotherapy by the HDAC inhibitor, romidepsin activates the anti- apoptotic transcription factor NF-κB in A549 non-small cell lung cancer (NSCLC) cells and fails to induce significant levels of apoptosis. We also demonstrated that NF-κB inhibition with proteasome inhibitor bortezomib enhanced HDAC inhibitor induced mitochondrial injury and sensitize A549 NSCLC cells to apoptosis through the generation of reactive oxygen species. In this study, we investigate whether combined treatment with romidepsin and bortezomib would induce apoptosis in A549 NSCLC cells by activating cell cycle arrest, enhanced generation of p21 and p53, down-regulation of matrix metalloproteinases (MMPs) 2,9 also altering the acetylation status of histone proteins. Our data show that combination of romidepsin and bortezomib caused cell cycle arrest at Sub G0-G1 transition, up-regulation of cell cycle protein p21 and tumour suppressor protein p53. In addition, romidepsin down-regulated the expression of MMP-2,9 and hyperacetylation of histone H3 and H4 in bortezomib sensitised A549 NSCLC cells. From this study we concluded that romidepsin and bortezomib cooperatively inhibit A549 NSCLC cell proliferation by altering the histone acetylation status, expression of cell cycle regulators and MMPs. Romidepsin along with bortezomib might be an effective treatment approach for A549 NSCLC cells.
Authors:
Selvaraju Karthik; Renu Sankar; Krishnamoorthy Varunkumar; Vilwanathan Ravikumar
Related Documents :
23964669 - Synthesis of fluorescent gold nanodot-liposome hybrids for detection of phospholipase c...
4056829 - Intracellular mucoid changes in tumor cells of meningiomas: a manifestation of polyviny...
24702989 - How tets and cytoskeleton dynamics met in reprogramming.
23612739 - P27kip1 knockdown induces proliferation in the organ of corti in culture after efficien...
18469359 - A counting strategy for estimating plasma cell number in cd138-stained bone marrow core...
24288439 - The influence of oral bacteria on epithelial cell migration in vitro.
21595849 - Role of multifunctional cell cycle modulators in advanced secondary hyperparathyroidism.
19139819 - Novel herbal flavonoids promote apoptosis but differentially induce cell cycle arrest i...
7723229 - Cytotoxicity of mercury compounds in llc-pk1, mdck and human proximal tubular cells.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-1-15
Journal Detail:
Title:  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie     Volume:  -     ISSN:  1950-6007     ISO Abbreviation:  Biomed. Pharmacother.     Publication Date:  2014 Jan 
Date Detail:
Created Date:  2014-2-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8213295     Medline TA:  Biomed Pharmacother     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014 Elsevier Masson SAS. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Gene expression signatures of primary and metastatic uterine leiomyosarcoma.
Next Document:  Modafinil combined with cognitive training is associated with improved learning in healthy volunteer...